首页 | 本学科首页   官方微博 | 高级检索  
     


A phase 2, double-blinded,placebo-controlled trial of toll-like receptor 7/8/9 antagonist,IMO-8400, in dermatomyositis
Authors:Yoo Jung Kim  Elena Schiopu  Katalin Dankó  Tahseen Mozaffar  Srinivas Chunduru  Kirstin Lees  Namita A. Goyal  Jeffrey Sarazin  David F. Fiorentino  Kavita Y. Sarin
Affiliation:1. Department of Dermatology, Stanford University School of Medicine, Redwood City, California;2. Department of Rheumatology, University of Michigan, Ann Arbor, Michigan;3. Department of Clinical Immunology, Medical Faculty, University of Debrecen, Debrecen, Hungary;4. Department of Neurology, University of California Irvine, Irvine, California;5. Idera Pharmaceuticals, Inc, Exton, Pennsylvania
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号